Healthy adults (excluding those under 18, pregnant women, and lactating women, who were not suffering from any diseases)
Conditions
Interventions
None listed
Sponsors
FUJIFILM Corporation
Yakujihou Marketing Jimusho Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: A systematic literature search is performed through scientific and clinical trial registries databases. The selection criteria are as follows. P: Healthy adults (excluding those under 18, pregnant women, and lactating women, who were not suffering from any diseases). Intervention: Intake of foods (capsules, tablets, drinks, foods) containing salacinol. C-Control: Intake of a placebo that does not contain salacinol. O-Outcome: Fecal Bifidobacterium rate, which correlates intestinal regulating effects. Changes in fecal Bifidobacterium rate, defecation frequency.
Exclusion criteria
Exclusion criteria: Studies which do not meet the key inclusion criteria will be excluded. Intervention studies without a placebo intake group are excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fecal Bifidobacterium rate, which correlates intestinal regulating effects | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in fecal Bifidobacterium rate, defecation frequency | — |
Countries
Japan
Contacts
Public ContactYoshiyuki Shirakura
FUJIFILM Corporation Consumer Healthcare Business Div.
Outcome results
None listed